Krebs Biochemicals & Industries Q2 Results FY27: Net Loss Narrows 12.05% to Rs 5.40 Cr on Revenue of Rs 5.79 Cr

Krebs Biochemicals & Industries Ltd (KREBSBIO) Q2 Results FY27 announced on 29 October 2026, covering the company's financial performance for the July to September quarter. The results date brings Krebs Biochemicals & Industries Q2 Results FY27 on a Standalone basis, with revenue of Rs 5.79 Cr and net loss of Rs 5.40 Cr. Compared with the same quarter last year, revenue was up 38.85% and the net loss was Rs 5.40 Cr, narrower by 12.05% than the net loss of Rs 6.14 Cr a year earlier. These standalone results are the base for the analysis that follows.

This results analysis of Krebs Biochemicals & Industries Q2 Results covers the financial highlights, the business drivers, the outlook and the key risks. Univest readers can use the Univest Screener alongside it to track how Krebs Biochemicals & Industries compares on other metrics. The Financial Highlights section opens the numbers.

Click Here – Get Free Investment Predictions

Krebs Biochemicals & Industries Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 5.79 Cr	Rs 4.17 Cr	+38.85% YoY
Operating Profit	Rs -1.93 Cr	Rs -2.79 Cr	+30.82% YoY
Net Profit (PAT)	Rs -5.4 Cr	Rs -6.14 Cr	+12.05% YoY

Source: company filing for Krebs Biochemicals & Industries Q2 Results FY27, 29 October 2026. Figures in Rs Crore, Standalone basis.

Key Takeaways from Krebs Biochemicals & Industries Q2 Results: What Stands Out

• Revenue: Krebs Biochemicals & Industries reported revenue of Rs 5.79 Cr, up 38.85% YoY against Rs 4.17 Cr in the same quarter of the previous year.
• Net loss: Net loss stood at Rs 5.40 Cr, narrower by 12.05% than the net loss of Rs 6.14 Cr a year earlier, which sets the YoY growth picture for the bottom line.
• Operating Profit: Operating Profit came in at Rs -1.93 Cr, an improvement of 30.82% from Rs -2.79 Cr a year earlier, which adds a third line to the YoY growth comparison.
• Basis: Krebs Biochemicals & Industries Q2 Results FY27 are standalone results declared on 29 October 2026, so every figure in this article follows that single reporting basis.
• Margin: Net profit margin improved to -93.3% from -147.2% in the comparison quarter. This links the revenue and net profit lines in the same quarter.
• Next: The performance analysis below sets out how revenue and profit moved against the same quarter last year.

Krebs Biochemicals & Industries Q2 Results FY27: Performance Analysis

Krebs Biochemicals & Industries Q2 Results FY27 show that Krebs Biochemicals & Industries reported revenue of Rs 5.79 Cr, up 38.85% YoY, and net loss of Rs 5.40 Cr, narrower by 12.05% than the net loss of Rs 6.14 Cr a year earlier. Operating Profit was Rs -1.93 Cr, an improvement of 30.82% from Rs -2.79 Cr a year earlier. These are the headline standalone results for the quarter.

The same quarter last year recorded revenue of Rs 4.17 Cr and a net loss of Rs 6.14 Cr, which is the base for every YoY growth figure here. In Krebs Biochemicals & Industries Q2 Results, the revenue change of 38.85% and the net profit change, a net loss that is 12.05% narrower than the Rs 6.14 Cr net loss a year earlier, move at different rates, so the two lines are best read together.

The quarterly results therefore give two readings: a top-line change of 38.85% and a bottom-line net loss of Rs 5.40 Cr. Krebs Biochemicals & Industries Q2 Results FY27 also leave the next question open, namely what drove these numbers, which is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Trend – The results analysis points to this first business factor. Revenue grew 38.8% year on year to Rs 5.79 Cr in the latest quarter. Revenue is the first line of the statement, so this movement sets the base for every profit figure that follows in the results.

Net Profit Margin – Net profit margin improved to -93.3% from -147.2% in the comparison quarter. Margin shows how much of each rupee of revenue reached net profit, which links the revenue figure to the bottom line in the same quarter. Krebs Biochemicals & Industries Q2 Results FY27 carry this into the standalone results reported on 29 October 2026.

Debt Level – Company is almost debt free, with a debt-to-assets ratio of -1.38 in FY26. This balance-sheet reference sits alongside the quarterly figures and frames how the reported profit relates to the company's borrowings. The quarterly results place it next to the headline revenue and net profit figures.

FY27 Outlook After Krebs Biochemicals & Industries Q2 Results

The FY27 view starts from what the quarter shows for Krebs Biochemicals & Industries. Krebs Biochemicals & Industries has reported revenue of Rs 5.79 Cr and net loss of Rs 5.40 Cr for Q2, and full-year FY27 results will depend on the quarters still to be declared.

The results analysis for FY27 therefore rests on subsequent quarterly disclosures and on disclosed sector conditions, not on any projection. The net loss of Rs 5.40 Cr is one data point in that series, and readers can follow later filings on Univest. That makes it important to review the risks recorded for this quarter.

Key Risks to Watch After Krebs Biochemicals & Industries Q2 Results FY27

Net Loss

Company reported a net loss of Rs 5.40 Cr in the latest quarter. A loss in the latest quarter makes the direction of the next disclosure the key item to follow. This sits next to the YoY growth of 38.85% in revenue reported in Krebs Biochemicals & Industries Q2 Results FY27.

Return on Equity

Return on equity was low at 0.00% in FY26. A weak ratio indicates how little annual profit is generated per rupee of shareholder equity and is a reference for the quality of earnings.

Return on Capital Employed

Return on capital employed was modest at -15.38% in FY26. A modest ratio indicates how much operating earnings the business generates on the capital employed in it over a full year. The next disclosure will show whether this level continues.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Krebs Biochemicals & Industries Q2 Results FY27 show revenue of Rs 5.79 Cr and net loss of Rs 5.40 Cr on a Standalone basis, declared on 29 October 2026. These quarterly results should be read together with the risks above and the reference ratios listed. For a quick summary of Krebs Biochemicals & Industries Q2 Results, these standalone results are the figures to note. Investors should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Krebs Biochemicals & Industries Q2 Results FY27

What are Krebs Biochemicals & Industries Q2 Results FY27?

Ans. Krebs Biochemicals & Industries Q2 Results FY27 report revenue of Rs 5.79 Cr and net loss of Rs 5.40 Cr for July to September 2026. Alongside this, the Quick Answer summarises both figures.

What is the results date for Krebs Biochemicals & Industries Q2 Results FY27?

Ans. Krebs Biochemicals & Industries declared its quarterly results on 29 October 2026 for the July to September 2026 quarter. This results date applies to the standalone results covered in the introduction of this article.

What revenue was reported in Krebs Biochemicals & Industries Q2 Results FY27?

Ans. Krebs Biochemicals & Industries reported revenue of Rs 5.79 Cr, compared with Rs 4.17 Cr a year earlier, so the Financial Highlights table shows the YoY change as up 38.85%.

What net profit was reported in Krebs Biochemicals & Industries Q2 Results FY27?

Ans. Krebs Biochemicals & Industries reported a net loss of Rs 5.40 Cr, narrower by 12.05% than the net loss of Rs 6.14 Cr a year earlier, while the Performance Analysis section explains how this compares with revenue.

How much YoY growth did revenue show in Krebs Biochemicals & Industries Q2 Results FY27?

Ans. Revenue moved up 38.85% YoY to Rs 5.79 Cr, which means the top line grew against Rs 4.17 Cr; the Key Takeaways section lists this first for the quarter.

Did net profit rise or fall in Krebs Biochemicals & Industries Q2 Results?

Ans. The net loss was Rs 5.40 Cr against Rs 6.14 Cr a year earlier, so the YoY direction is a narrower loss; the Performance Analysis section sets this against revenue.

What was the Operating Profit in Krebs Biochemicals & Industries Q2 Results FY27?

Ans. Krebs Biochemicals & Industries Q2 Results FY27 show Operating Profit of Rs -1.93 Cr, an improvement of 30.82% from Rs -2.79 Cr a year earlier. Alongside this, the Performance Analysis section sets it against revenue of Rs 5.79 Cr.

Are Krebs Biochemicals & Industries Q2 Results consolidated results or standalone results?

Ans. Krebs Biochemicals & Industries Q2 Results are standalone results reported by Krebs Biochemicals & Industries on 29 October 2026, so every figure follows that basis, as the Quick Answer and Conclusion state.

What business factors shaped Krebs Biochemicals & Industries Q2 Results FY27?

Ans. The business factors include: Revenue grew 38.8% year on year to Rs 5.79 Cr in the latest quarter. Alongside this, the Key Business Factors section lists the others.

What are the key risks after Krebs Biochemicals & Industries Q2 Results FY27?

Ans. The risks include: Company reported a net loss of Rs 5.40 Cr in the latest quarter. Alongside this, the Key Risks to Watch section covers the others.

What is the outlook after Krebs Biochemicals & Industries Q2 Results?

Ans. The FY27 view rests on later quarterly disclosures and disclosed sector conditions, which means the FY27 Outlook section stays tied to the Q2 numbers reported so far for Krebs Biochemicals & Industries.

Where can I find the complete Krebs Biochemicals & Industries Q2 Results FY27 data?

Ans. The Financial Highlights table in this article lists revenue and net profit for the quarter and the same quarter last year, and the Univest Screener tracks Krebs Biochemicals & Industries alongside other companies.